Sinusitis

Sinusitis means your sinuses are infected or inflamed. Your sinuses are hollow air spaces within the bones surrounding the nose. They produce mucus, which drains into the nose. If your nose is swollen, this can block the sinuses and cause pain and infection. Sinusitis can be acute, lasting for less than four weeks, or chronic, lasting much longer. Acute sinusitis often starts as a cold, which then turns into a bacterial infection. Allergies, pollutants, nasal problems and certain diseases can also cause sinusitis. Symptoms of sinusitis can include fever, weakness, fatigue, cough and congestion. There may also be mucus drainage in the back of the throat, called postnasal drip. Treatments include antibiotics, decongestants and pain relievers. Using heat pads on the inflamed area, saline nasal sprays and vaporizers can also help.
What is sinusitis?

The sinuses are hollow air filled cavities within the skull bones. There are four pars of sinuses and these are located behind the forehead (a pair), under the cheek bones (a pair), behind the eyes (a pair) and on either side of the bridge of the nose (a pair).

Read More

Overview

Feature Articles

Latest Sinusitis News and Research

Novel, affordable pneumonia vaccine tested in human patients

Novel, affordable pneumonia vaccine tested in human patients

COVID19 patients describe a loss of smell and taste

COVID19 patients describe a loss of smell and taste

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

Blue Water Vaccines enters into agreement to develop Streptococcus pneumoniae vaccine with St. Jude

2019-nCoV: Infectious virus can be isolated from nose, throat swabs of patients with mild symptoms

2019-nCoV: Infectious virus can be isolated from nose, throat swabs of patients with mild symptoms

Nasal sprays cut down usage of antibiotics for individuals with chronic rhinosinusitis

Nasal sprays cut down usage of antibiotics for individuals with chronic rhinosinusitis

Study shows how Chlamydia bacteria enter human cells

Study shows how Chlamydia bacteria enter human cells

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Only half of patients with sinus, throat, or ear infections receive first-line antibiotics

Stem cells with 'dual identity' associated with loss of smell from inflammation in chronic sinusitis

Stem cells with 'dual identity' associated with loss of smell from inflammation in chronic sinusitis

Australian doctors are overprescribing flu antivirals, study reveals

Australian doctors are overprescribing flu antivirals, study reveals

Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients

Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

Johns Hopkins researchers find genetic cause of olfactory neuroblastoma

Unique form of chronic sinusitis found in older patients

Unique form of chronic sinusitis found in older patients

MUHC's 'Dr. House' discovers new genetic disease and the gene responsible for it

MUHC's 'Dr. House' discovers new genetic disease and the gene responsible for it

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Pooled analysis of Intersect ENT's steroid releasing implants in patients after frontal sinus surgery to be published

Study shows how pneumococci challenge the immune system

Study shows how pneumococci challenge the immune system

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Scientists perform successful trial of new antibiotic on cancer reoccurrence after surgery

Most commonly prescribed drugs to primary care patients are not often tested

Most commonly prescribed drugs to primary care patients are not often tested